ABT-089, A Neuronal Nicotinic Receptor Partial Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Pilot Study
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Biological Psychiatry
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Abbott Laboratories
OpenAlex ID: W2044210997
